The listing and offering terms

Windward Bio listed on Nasdaq on November 13, 2026, according to investor Qiming Venture Partners’ November 14 announcement.

Windward’s November 12 pricing release, filed with the SEC, sets out an IPO of 10,294,117 common shares at $17 each. It identifies the Nasdaq Global Select Market and the symbol WWB.

How the financing is split

The IPO share count corresponds to approximately $175 million. A concurrent private placement to Sanofi Foreign Participations B.V. has a stated purchase price of $50 million.

Windward’s expected $225 million gross total combines those transactions, before underwriting discounts, commissions and offering expenses, and excludes the underwriters’ additional-share option.

Expected closing

The issuer expects the offering to close on November 16, subject to customary conditions. The concurrent private placement is also scheduled for that date and depends on completion of the IPO.